Aurinia Pharmaceuticals (AUPH) Other Gross PP&E Adjustments (2019 - 2025)
Aurinia Pharmaceuticals' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$6.1 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 92.93% year-over-year to -$6.1 million; the TTM value through Dec 2025 reached -$6.1 million, up 92.93%, while the annual FY2025 figure was -$6.1 million, 92.93% up from the prior year.
- Other Gross PP&E Adjustments reached -$6.1 million in Q4 2025 per AUPH's latest filing, up from -$73.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.1 million in Q4 2022 to a low of -$107.8 million in Q3 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$26.9 million, with a median of -$212500.0 recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 4057.36% in 2022, then tumbled 88476.23% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$129000.0 in 2021, then surged by 4057.36% to $5.1 million in 2022, then plummeted by 2126.46% to -$103.5 million in 2023, then grew by 16.09% to -$86.8 million in 2024, then soared by 92.93% to -$6.1 million in 2025.
- Per Business Quant, the three most recent readings for AUPH's Other Gross PP&E Adjustments are -$6.1 million (Q4 2025), -$73.5 million (Q3 2025), and -$77.9 million (Q2 2025).